HUMA

SEC source: 0001818382-22-000221 · wf-form4_167149938921327.xml · nonDerivative · entry 1

Niklason Laura E · CIK 0001878075 · Director · President, CEO and Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Ayabudge LLC

Disclosed balance after: 17,990,736

F1 · shares: The sales were made by Ayabudge LLC, an entity controlled by Brady W. Dougan. The transactions enabled Mr. Dougan to pay down leverage while providing a mechanism for the purchasers to acquire shares of the Issuer at a time that the Issuer was not conducting a financing transaction and was not making any additional shares available for purchase. Mr. Dougan, directly and indirectly, remains the largest shareholder of the Issuer. Dr. Niklason is treated as indirectly beneficially owning the shares sold, resulting in the requirement to file this Form 4. However, no shares directly owned by Dr. Niklason were sold in these transactions.

F2 · price: The price is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $2.50 to $2.63. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001818382-22-000224 · wf-form4_167149975005868.xml · nonDerivative · entry 2

Sander Dale A. · CIK 0001878193 · CFO and Chief Corp. Deve. Off.

10b5-1 filing: Not disclosed

Ownership: Indirect · By spouse

Disclosed balance after: 20,600

SEC source: 0001818382-22-000220 · wf-form4_167149929109468.xml · nonDerivative · entry 1

Dougan Brady W · CIK 0001878020 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Ayabudge LLC

Disclosed balance after: 17,990,736

F1 · shares: The sales were made by Ayabudge LLC, an entity controlled by Brady W. Dougan. The transactions enabled Mr. Dougan to pay down leverage while providing a mechanism for the purchasers to acquire shares of the Issuer at a time that the Issuer was not conducting a financing transaction and was not making any additional shares available for purchase. Mr. Dougan, directly and indirectly, remains the largest shareholder of the Issuer.

F2 · price: The price is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $2.50 to $2.63. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001818382-22-000219 · wf-form4_167149916039845.xml · nonDerivative · entry 1

Ayabudge LLC · CIK 0001878024 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,990,736

F1 · shares: On December 16, 2022, the Reporting Person sold 239,538 shares of Common Stock. The transactions enabled Mr. Brady W. Dougan, a person controlling the Reporting Person, to pay down leverage while providing a mechanism for the purchasers to acquire shares of the Issuer at a time that the Issuer was not conducting a financing transaction and was not making any additional shares available for purchase. Mr. Dougan, directly and indirectly, remains the largest shareholder of the Issuer.

F2 · price: The price is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $2.50 to $2.63. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001818382-22-000211 · wf-form4_167115188797248.xml · nonDerivative · entry 3

Niklason Laura E · CIK 0001878075 · Director · President, CEO and Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Ayabudge LLC

Disclosed balance after: 18,230,274

F1 · shares: The sales were made by Ayabudge LLC, an entity controlled by Brady W. Dougan. The transactions enabled Mr. Dougan to pay down leverage while providing a mechanism for the purchasers to acquire shares of the Issuer at a time that the Issuer was not conducting a financing transaction and was not making any additional shares available for purchase. Mr. Dougan, directly and indirectly, remains the largest shareholder of the Issuer. Dr. Niklason is treated as indirectly beneficially owning the shares sold, resulting in the requirement to file this Form 4. However, no shares directly owned by Dr. Niklason were sold in these transactions.

F4 · price: The price is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $2.60 to $2.80. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001818382-22-000210 · wf-form4_167115176325311.xml · nonDerivative · entry 3

Dougan Brady W · CIK 0001878020 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Ayabudge LLC

Disclosed balance after: 18,230,274

F1 · shares: The sales were made by Ayabudge LLC, an entity controlled by Brady W. Dougan. The transactions enabled Mr. Dougan to pay down leverage while providing a mechanism for the purchasers to acquire shares of the Issuer at a time that the Issuer was not conducting a financing transaction and was not making any additional shares available for purchase. Mr. Dougan, directly and indirectly, remains the largest shareholder of the Issuer.

F4 · price: The price is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $2.60 to $2.80. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001818382-22-000209 · wf-form4_167115157790775.xml · nonDerivative · entry 3

Ayabudge LLC · CIK 0001878024 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,230,274

F1 · shares: On December 13, 14 and 15, 2022, the Reporting Person sold 330,000, 276,304 and 93,426 shares of Common Stock, respectively. The transactions enabled Mr. Brady W. Dougan, a person controlling the Reporting Person, to pay down leverage while providing a mechanism for the purchasers to acquire shares of the Issuer at a time that the Issuer was not conducting a financing transaction and was not making any additional shares available for purchase. Mr. Dougan, directly and indirectly, remains the largest shareholder of the Issuer.

F4 · price: The price is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $2.60 to $2.80. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001818382-22-000223 · wf-form4_167149963704147.xml · nonDerivative · entry 1

Niklason Laura E · CIK 0001878075 · Director · President, CEO and Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,170,240

F1 · shares: This purchase is matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended, against a portion of the sale by Ayabudge LLC, an entity controlled by the Reporting Person's spouse, of 1,522,500 shares of the Issuer's common stock on September 15, 2022, at a per share price of $4.00. The Reporting Person has paid the Issuer $14,604.95, representing the full amount of profit realized in connection with this purchase.

F2 · price: The price is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $2.53 to $2.55. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

SEC source: 0001818382-22-000222 · wf-form4_167149950807724.xml · nonDerivative · entry 1

Dougan Brady W · CIK 0001878020 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By spouse

Disclosed balance after: 1,170,240

F1 · shares: This purchase by the Reporting Person's spouse is matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended, against a portion of the sale by Ayabudge LLC, an entity controlled by the Reporting Person, of 1,522,500 shares of the Issuer's common stock on September 15, 2022, at a per share price of $4.00. The Reporting Person's spouse has paid the Issuer $14,604.95, representing the full amount of profit realized in connection with this purchase.

F2 · price: The price is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $2.53 to $2.55. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

SEC source: 0001818382-22-000211 · wf-form4_167115188797248.xml · nonDerivative · entry 2

Niklason Laura E · CIK 0001878075 · Director · President, CEO and Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Ayabudge LLC

Disclosed balance after: 18,323,700

F1 · shares: The sales were made by Ayabudge LLC, an entity controlled by Brady W. Dougan. The transactions enabled Mr. Dougan to pay down leverage while providing a mechanism for the purchasers to acquire shares of the Issuer at a time that the Issuer was not conducting a financing transaction and was not making any additional shares available for purchase. Mr. Dougan, directly and indirectly, remains the largest shareholder of the Issuer. Dr. Niklason is treated as indirectly beneficially owning the shares sold, resulting in the requirement to file this Form 4. However, no shares directly owned by Dr. Niklason were sold in these transactions.

F3 · price: The price is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $2.75 to $2.87. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001818382-22-000210 · wf-form4_167115176325311.xml · nonDerivative · entry 2

Dougan Brady W · CIK 0001878020 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Ayabudge LLC

Disclosed balance after: 18,323,700

F1 · shares: The sales were made by Ayabudge LLC, an entity controlled by Brady W. Dougan. The transactions enabled Mr. Dougan to pay down leverage while providing a mechanism for the purchasers to acquire shares of the Issuer at a time that the Issuer was not conducting a financing transaction and was not making any additional shares available for purchase. Mr. Dougan, directly and indirectly, remains the largest shareholder of the Issuer.

F3 · price: The price is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $2.75 to $2.87. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001818382-22-000209 · wf-form4_167115157790775.xml · nonDerivative · entry 2

Ayabudge LLC · CIK 0001878024 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,323,700

F1 · shares: On December 13, 14 and 15, 2022, the Reporting Person sold 330,000, 276,304 and 93,426 shares of Common Stock, respectively. The transactions enabled Mr. Brady W. Dougan, a person controlling the Reporting Person, to pay down leverage while providing a mechanism for the purchasers to acquire shares of the Issuer at a time that the Issuer was not conducting a financing transaction and was not making any additional shares available for purchase. Mr. Dougan, directly and indirectly, remains the largest shareholder of the Issuer.

F3 · price: The price is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $2.75 to $2.87. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001818382-22-000212 · wf-form4_167115202101303.xml · nonDerivative · entry 1

Scheessele William John · CIK 0001879378 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,525

SEC source: 0001818382-22-000211 · wf-form4_167115188797248.xml · nonDerivative · entry 1

Niklason Laura E · CIK 0001878075 · Director · President, CEO and Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Ayabudge LLC

Disclosed balance after: 18,600,004

F1 · shares: The sales were made by Ayabudge LLC, an entity controlled by Brady W. Dougan. The transactions enabled Mr. Dougan to pay down leverage while providing a mechanism for the purchasers to acquire shares of the Issuer at a time that the Issuer was not conducting a financing transaction and was not making any additional shares available for purchase. Mr. Dougan, directly and indirectly, remains the largest shareholder of the Issuer. Dr. Niklason is treated as indirectly beneficially owning the shares sold, resulting in the requirement to file this Form 4. However, no shares directly owned by Dr. Niklason were sold in these transactions.

F2 · price: The price is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $2.77 to $3.06. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001818382-22-000210 · wf-form4_167115176325311.xml · nonDerivative · entry 1

Dougan Brady W · CIK 0001878020 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Ayabudge LLC

Disclosed balance after: 18,600,004

F1 · shares: The sales were made by Ayabudge LLC, an entity controlled by Brady W. Dougan. The transactions enabled Mr. Dougan to pay down leverage while providing a mechanism for the purchasers to acquire shares of the Issuer at a time that the Issuer was not conducting a financing transaction and was not making any additional shares available for purchase. Mr. Dougan, directly and indirectly, remains the largest shareholder of the Issuer.

F2 · price: The price is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $2.77 to $3.06. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001818382-22-000209 · wf-form4_167115157790775.xml · nonDerivative · entry 1

Ayabudge LLC · CIK 0001878024 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,600,004

F1 · shares: On December 13, 14 and 15, 2022, the Reporting Person sold 330,000, 276,304 and 93,426 shares of Common Stock, respectively. The transactions enabled Mr. Brady W. Dougan, a person controlling the Reporting Person, to pay down leverage while providing a mechanism for the purchasers to acquire shares of the Issuer at a time that the Issuer was not conducting a financing transaction and was not making any additional shares available for purchase. Mr. Dougan, directly and indirectly, remains the largest shareholder of the Issuer.

F2 · price: The price is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $2.77 to $3.06. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001818382-22-000224 · wf-form4_167149975005868.xml · nonDerivative · entry 1

Sander Dale A. · CIK 0001878193 · CFO and Chief Corp. Deve. Off.

10b5-1 filing: Not disclosed

Ownership: Indirect · By spouse

Disclosed balance after: 600

SEC source: 0001818382-22-000203 · wf-form4_167096559281877.xml · derivative · entry 2

Prichard Heather Ledbetter · CIK 0001877712 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,564 shares

Expires 2022-12-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001818382-22-000203 · wf-form4_167096559281877.xml · nonDerivative · entry 1

Prichard Heather Ledbetter · CIK 0001877712 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,189

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001818382-22-000201 · wf-form4_167087968780298.xml · derivative · entry 1

Scheessele William John · CIK 0001879378 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 136,000

Underlying: Common Stock · 136,000 shares

Expires 2032-12-08

F1 · derivative.exercise_date: The first 25% of the option becomes exercisable on December 8, 2023, after which 1/48 of the option will become exercisable on the 8th of each month through December 8, 2026.

SEC source: 0001818382-22-000200 · wf-form4_167087967122662.xml · derivative · entry 1

Sander Dale A. · CIK 0001878193 · CFO and Chief Corp. Deve. Off.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 136,000

Underlying: Common Stock · 136,000 shares

Expires 2032-12-08

F1 · derivative.exercise_date: The first 25% of the option becomes exercisable on December 8, 2023, after which 1/48 of the option will become exercisable on the 8th of each month through December 8, 2026.

SEC source: 0001818382-22-000197 · wf-form4_167087945823074.xml · derivative · entry 1

Niklason Laura E · CIK 0001878075 · Director · President, CEO and Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 444,500

Underlying: Common Stock · 444,500 shares

Expires 2032-12-08

F1 · derivative.exercise_date: The first 25% of the option becomes exercisable on December 8, 2023, after which 1/48 of the option will become exercisable on the 8th of each month through December 8, 2026.

SEC source: 0001818382-22-000196 · wf-form4_167087932464065.xml · derivative · entry 1

Dougan Brady W · CIK 0001878020 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By spouse

Disclosed balance after: 444,500

Underlying: Common Stock · 444,500 shares

Expires 2032-12-08

F1 · derivative.exercise_date: The first 25% of the option becomes exercisable on December 8, 2023, after which 1/48 of the option will become exercisable on the 8th of each month through December 8, 2026.

SEC source: 0001818382-22-000199 · wf-form4_167087964180804.xml · derivative · entry 1

Prichard Heather Ledbetter · CIK 0001877712 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 136,000

Underlying: Common Stock · 136,000 shares

Expires 2032-12-08

F1 · derivative.exercise_date: The first 25% of the option becomes exercisable on December 8, 2023, after which 1/48 of the option will become exercisable on the 8th of each month through December 8, 2026.

SEC source: 0001818382-22-000198 · wf-form4_167087961711138.xml · derivative · entry 1

Parikh Shamik J · CIK 0001916853 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 91,120

Underlying: Common Stock · 91,120 shares

Expires 2032-12-08

F1 · derivative.exercise_date: The first 25% of the option becomes exercisable on December 8, 2023, after which 1/48 of the option will become exercisable on the 8th of each month through December 8, 2026.

SEC source: 0001818382-22-000174 · wf-form4_166370457260068.xml · derivative · entry 1

Cao Yang · CIK 0001946538 · Chief Regulatory Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 145,000

Underlying: Common Stock · 145,000 shares

Expires 2032-09-19

F1 · derivative.exercise_date: The first 25% of the option becomes exercisable on September 19, 2023, after which 1/48 of the option will become exercisable on the 19th of each month through September 19, 2026.

SEC source: 0001818382-22-000165 · wf-form4_166362019050673.xml · derivative · entry 1

Green Charles Bruce · CIK 0001945398 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,000

Underlying: Common Stock · 13,000 shares

Expires 2032-09-15

F1 · derivative.exercise_date: The first 25% of the option becomes exercisable on September 15, 2023, after which 1/48 of the option will become exercisable on the 15th of each month through September 15, 2026.

SEC source: 0001818382-22-000160 · wf-form4_166361966655292.xml · nonDerivative · entry 1

Dougan Brady W · CIK 0001878020 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Ayabudge LLC

Disclosed balance after: 18,930,004

F1 · shares: The sale was made by Ayabudge LLC, an entity controlled by Brady W Dougan, in a block trade. The purchaser is an existing investor of the Issuer, who had previously participated in the Issuer's PIPE financing transaction, and was interested in increasing its ownership of the Humacyte, Inc. The transaction enabled Mr. Dougan to pay down leverage while providing a mechanism for the purchaser to acquire a large block of shares at a time that Humacyte, Inc. was not conducting a financing and was not making any additional shares available for purchase. Mr. Dougan, directly and indirectly, remains the largest shareholder of the Issuer.

SEC source: 0001818382-22-000167 · wf-form4_166362046815607.xml · nonDerivative · entry 1

Niklason Laura E · CIK 0001878075 · Director · President, CEO and Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,160,240

SEC source: 0001818382-22-000161 · wf-form4_166361976999359.xml · nonDerivative · entry 1

Niklason Laura E · CIK 0001878075 · Director · President, CEO and Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Ayabudge LLC

Disclosed balance after: 18,930,004

F1 · shares: This sale was made by an entity controlled by the spouse of Laura Niklason, the Reporting Person. This sale was done as a block trade to an existing investor of Humacyte, Inc. Laura Niklason is treated as indirectly beneficially owning the shares sold, resulting in the requirement to file this Form 4. However, no shares directly owned by Laura Niklason were sold in this transaction.

SEC source: 0001818382-22-000166 · wf-form4_166362031175064.xml · nonDerivative · entry 1

Dougan Brady W · CIK 0001878020 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By spouse

Disclosed balance after: 1,160,240

SEC source: 0001818382-22-000159 · wf-form4_166361956732744.xml · nonDerivative · entry 1

Ayabudge LLC · CIK 0001878024 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,930,004

F1 · shares: The sale was made by the Reporting Person in a block trade. The purchaser is an existing investor of the Issuer, who had previously participated in the Issuer's PIPE financing transaction, and was interested in increasing its ownership of the Humacyte, Inc. The transaction enabled Mr. Brady Dougan, a person controlling the Reporting Person, to pay down leverage while providing a mechanism for the purchaser to acquire a large block of shares at a time that Humacyte, Inc. was not conducting a financing and was not making any additional shares available for purchase. Mr. Dougan, directly and indirectly, remains the largest shareholder of the Issuer.

SEC source: 0001818382-22-000119 · wf-form4_166249526500566.xml · nonDerivative · entry 1

Binder Gordon M · CIK 0001291957 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 110,000

F1 · price: The shares were purchased in multiple transactions at per share prices ranging from $4.20 to $4.70. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

SEC source: 0001818382-22-000117 · wf-form4_166206771163271.xml · nonDerivative · entry 1

Binder Gordon M · CIK 0001291957 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,159

F1 · price: The shares were purchased in multiple transactions at per share prices ranging from $3.53 to $4.20. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

SEC source: 0001818382-22-000087 · wf-form4_165515148138255.xml · derivative · entry 1

Seimetz Diane · CIK 0001930980 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,000

Underlying: Common Stock · 13,000 shares

Expires 2032-06-09

F1 · derivative.exercise_date: The first 25% of the option becomes exercisable on June 9, 2023, after which 1/48 of the option will become exercisable on the 9th of each month through June 9, 2026.

SEC source: 0001818382-22-000095 · wf-form4_165515177398575.xml · derivative · entry 1

Brown Emery N. · CIK 0001878691 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,500

Underlying: Common Stock · 8,500 shares

Expires 2032-06-09

F1 · derivative.exercise_date: The first 25% of the option becomes exercisable on June 9, 2023, after which 1/48 of the option will become exercisable on the 9th of each month through June 9, 2026.

SEC source: 0001818382-22-000089 · wf-form4_165515163845765.xml · derivative · entry 1

Niklason Laura E · CIK 0001878075 · Director · President, CEO and Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By spouse

Disclosed balance after: 8,500

Underlying: Common Stock · 8,500 shares

Expires 2032-06-09

F1 · derivative.exercise_date: The first 25% of the option becomes exercisable on June 9, 2023, after which 1/48 of the option will become exercisable on the 9th of each month through June 9, 2026.

SEC source: 0001818382-22-000088 · wf-form4_165515158910639.xml · derivative · entry 1

Dougan Brady W · CIK 0001878020 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,500

Underlying: Common Stock · 8,500 shares

Expires 2032-06-09

F1 · derivative.exercise_date: The first 25% of the option becomes exercisable on June 9, 2023, after which 1/48 of the option will become exercisable on the 9th of each month through June 9, 2026.

SEC source: 0001818382-22-000093 · wf-form4_165515173318572.xml · derivative · entry 1

Wallace Max N. · CIK 0001877453 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,500

Underlying: Common Stock · 8,500 shares

Expires 2032-06-09

F1 · derivative.exercise_date: The first 25% of the option becomes exercisable on June 9, 2023, after which 1/48 of the option will become exercisable on the 9th of each month through June 9, 2026.

SEC source: 0001818382-22-000097 · wf-form4_165515180978252.xml · derivative · entry 1

Binder Gordon M · CIK 0001291957 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,500

Underlying: Common Stock · 8,500 shares

Expires 2032-06-09

F1 · derivative.exercise_date: The first 25% of the option becomes exercisable on June 9, 2023, after which 1/48 of the option will become exercisable on the 9th of each month through June 9, 2026.

SEC source: 0001818382-22-000096 · wf-form4_165515179132864.xml · derivative · entry 1

Sebelius Kathleen · CIK 0001654316 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,500

Underlying: Common Stock · 8,500 shares

Expires 2032-06-09

F1 · derivative.exercise_date: The first 25% of the option becomes exercisable on June 9, 2023, after which 1/48 of the option will become exercisable on the 9th of each month through June 9, 2026.

SEC source: 0001818382-22-000094 · wf-form4_165515175246689.xml · derivative · entry 1

Shukla Rajiv · CIK 0001709033 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,500

Underlying: Common Stock · 8,500 shares

Expires 2032-06-09

F1 · derivative.exercise_date: The first 25% of the option becomes exercisable on June 9, 2023, after which 1/48 of the option will become exercisable on the 9th of each month through June 9, 2026.

SEC source: 0001818382-22-000092 · wf-form4_165515171376202.xml · derivative · entry 1

Windham-Bannister Susan Richards · CIK 0001713760 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,500

Underlying: Common Stock · 8,500 shares

Expires 2032-06-09

F1 · derivative.exercise_date: The first 25% of the option becomes exercisable on June 9, 2023, after which 1/48 of the option will become exercisable on the 9th of each month through June 9, 2026.

SEC source: 0001818382-22-000090 · wf-form4_165515166596398.xml · derivative · entry 1

Constantino Michael T. · CIK 0001817285 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,500

Underlying: Common Stock · 8,500 shares

Expires 2032-06-09

F1 · derivative.exercise_date: The first 25% of the option becomes exercisable on June 9, 2023, after which 1/48 of the option will become exercisable on the 9th of each month through June 9, 2026.

SEC source: 0001818382-22-000091 · wf-form4_165515169262942.xml · derivative · entry 1

Pope Todd · CIK 0001584367 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,500

Underlying: Common Stock · 8,500 shares

Expires 2032-06-09

F1 · derivative.exercise_date: The first 25% of the option becomes exercisable on June 9, 2023, after which 1/48 of the option will become exercisable on the 9th of each month through June 9, 2026.

SEC source: 0001818382-22-000053 · wf-form4_165349360232953.xml · nonDerivative · entry 1

Scheessele William John · CIK 0001879378 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,525

SEC source: 0001818382-22-000047 · wf-form4_165342327621043.xml · nonDerivative · entry 1

Constantino Michael T. · CIK 0001817285 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,500

SEC source: 0001818382-22-000050 · wf-form4_165348845280981.xml · nonDerivative · entry 1

Niklason Laura E · CIK 0001878075 · Director · President, CEO and Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,158,240

SEC source: 0001818382-22-000051 · wf-form4_165348852456360.xml · nonDerivative · entry 1

Dougan Brady W · CIK 0001878020 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By spouse

Disclosed balance after: 1,158,240

SEC source: 0001104659-22-062583 · tm2216009-1_4seq1.xml · nonDerivative · entry 1

Sander Dale A. · CIK 0001878193 · CFO and Chief Corp. Deve. Off.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,000